Cell Press

SHERPA: Unknown

People

  1. Rosen
    Rosen
  2. Robson
    Robson
  3. Chandarlapaty
    Chandarlapaty
  4. Offit
    Offit
  5. Norton
    Norton
  6. Razavi
    Razavi
  7. Solit
    Solit
  8. Berger
    Berger
  9. De Stanchina
    De Stanchina
  10. Brogi
    Brogi

Groups

  1. Breast Medicine Service (71)
  2. Department of Medicine (71)
  3. Solid Tumor Oncology Division (71)
  4. GSK Faculty (63)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (39)
  6. Sloan Kettering Institute Faculty (36)
  7. Sloan Kettering Institute Postdocs (32)
  8. Human Oncology and Pathogenesis Program (28)
  9. Molecular Pharmacology and Chemistry Program Faculty (24)
  10. Population Sciences Research Program (20)
Search Within
  1. "Breast Medicine Service"
Formats
  1. Journal Article (55)
  2. Meeting Abstract (10)
  3. Editorial (4)
  4. Miscellaneous (1)
  5. Review (1)
Groups
  1. Breast Medicine Service (71)
  2. Department of Medicine (71)
  3. Solid Tumor Oncology Division (71)
  4. GSK Faculty (63)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (39)
  6. Sloan Kettering Institute Faculty (36)

More Groups

People
  1. Larry Norton (19)
  2. Neal Rosen (19)
  3. Mark Robson (15)
  4. Sarat Chandarlapaty (14)
  5. Kenneth Offit (13)
  6. Pedram Razavi (11)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (4)
  6. 2020 (4)

More Years

Publications
  1. Cancer Cell (29)
  2. American Journal of Human Genetics (13)
  3. Cell (10)
  4. Cell Reports (6)
  5. Molecular Cell (6)
  6. Immunity (2)

More Publications

Results (71)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Customizing functionality and payload delivery for receptor-engineered T cells
    Journal Article

    Klebanoff, C. A.; Restifo, N. P.
    Cell (2016)

    Fulltext@MSK | Save
  • PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kα inhibition
    Journal Article

    Castel, P.; Ellis, H.; Bago, R.; Toska, E.; Razavi, P.; Carmona, F. J.; Kannan, S.; Verma, C. S.; Dickler, M.; Chandarlapaty, S.; more...
    Cancer Cell (2016)

    Fulltext@MSK | Save
  • Oxygen sensing by T cells establishes an immunologically tolerant metastatic niche
    Journal Article

    Clever, D.; Roychoudhuri, R.; Constantinides, M. G.; Askenase, M. H.; Sukumar, M.; Klebanoff, C. A.; Eil, R. L.; Hickman, H. D.; Yu, Z.; Pan, J. H.; more...
    Cell (2016)

    Fulltext@MSK | Save
  • When genome maintenance goes badly awry
    Journal Article

    Kass, E. M.; Moynahan, M. E.; Jasin, M.
    Molecular Cell (2016)

    Fulltext@MSK | Save
  • Evaluation of ACMG-guideline-based variant classification of cancer susceptibility and non-cancer-associated genes in families affected by breast cancer
    Journal Article

    Maxwell, K. N.; Hart, S. N.; Vijai, J.; Schrader, K. A.; Slavin, T. P.; Thomas, T.; Wubbenhorst, B.; Ravichandran, V.; Moore, R. M.; Hu, C.; more...
    American Journal of Human Genetics (2016)

    Fulltext@MSK | Save
  • Disabling of the erbB pathway followed by IFN-gamma modifies phenotype and enhances genotoxic eradication of breast tumors
    Journal Article

    Nagai, Y.; Tsuchiya, H.; Runkle, E. A.; Young, P. D.; Ji, M. Q.; Norton, L.; Drebin, J. A.; Zhang, H.; Greene, M. I.
    Cell Reports (2015)

    Fulltext@MSK | Save
  • BRAF mutants evade ERK-dependent feedback by different mechanisms that determine their sensitivity to pharmacologic inhibition
    Journal Article

    Yao, Z.; Torres, N. M.; Tao, A.; Gao, Y.; Luo, L.; Li, Q.; de Stanchina, E.; Abdel-Wahab, O.; Solit, D. B.; Poulikakos, P. I.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ
    Journal Article

    Schwartz, S.; Wongvipat, J.; Trigwell, C. B.; Hancox, U.; Carver, B. S.; Rodrik-Outmezguine, V. ; Will, M.; Yellen, P.; de Stanchina, E.; Baselga, J.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas
    Journal Article

    Elkabets, M.; Pazarentzos, E.; Juric, D.; Sheng, Q.; Pelossof, R. A.; Brook, S.; Benzaken, A. O.; Rodon, J.; Morse, N.; Yan, J. J.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Combination of RAF and MEK inhibition for the treatment of BRAF-mutated melanoma: Feedback is not encouraged
    Journal Article

    Chapman, P. B.; Solit, D. B.; Rosen, N.
    Cancer Cell (2014)

    Fulltext@MSK | Save

    • Cell Press – authorized name for: